Cancer stem cells—perspectives on current status and future directions: AACR Workshop on cancer stem cells MF Clarke, JE Dick, PB Dirks, CJ Eaves, CHM Jamieson, DL Jones, ... Cancer research 66 (19), 9339-9344, 2006 | 4088 | 2006 |
Granulocyte–macrophage progenitors as candidate leukemic stem cells in blast-crisis CML CHM Jamieson, LE Ailles, SJ Dylla, M Muijtjens, C Jones, JL Zehnder, ... New England Journal of Medicine 351 (7), 657-667, 2004 | 1903 | 2004 |
CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis S Jaiswal, CHM Jamieson, WW Pang, CY Park, MP Chao, R Majeti, ... Cell 138 (2), 271-285, 2009 | 1764 | 2009 |
Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia C Zhao, A Chen, CH Jamieson, M Fereshteh, A Abrahamsson, J Blum, ... Nature 458 (7239), 776-779, 2009 | 1160 | 2009 |
Stems cells and the pathways to aging and cancer DJ Rossi, CHM Jamieson, IL Weissman Cell 132 (4), 681-696, 2008 | 1100 | 2008 |
Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? E Passegué, CHM Jamieson, LE Ailles, IL Weissman Proceedings of the National Academy of Sciences 100 (suppl_1), 11842-11849, 2003 | 1082 | 2003 |
Cancer stem cells and self-renewal CA O'Brien, A Kreso, CHM Jamieson Clinical cancer research 16 (12), 3113-3120, 2010 | 586 | 2010 |
Chronic myeloid leukemia: mechanisms of blastic transformation D Perrotti, C Jamieson, J Goldman, T Skorski The Journal of clinical investigation 120 (7), 2254-2264, 2010 | 528 | 2010 |
Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis A Pardanani, JR Gotlib, C Jamieson, JE Cortes, M Talpaz, RM Stone, ... Journal of Clinical Oncology 29 (7), 789-796, 2011 | 497 | 2011 |
Pacritinib vs best available therapy, including ruxolitinib, in patients with myelofibrosis: a randomized clinical trial J Mascarenhas, R Hoffman, M Talpaz, AT Gerds, B Stein, V Gupta, ... JAMA oncology 4 (5), 652-659, 2018 | 391 | 2018 |
Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia T Sanda, LN Lawton, MI Barrasa, ZP Fan, H Kohlhammer, A Gutierrez, ... Cancer cell 22 (2), 209-221, 2012 | 369 | 2012 |
A first-in-human, phase I study of neural stem cell transplantation for chronic spinal cord injury E Curtis, JR Martin, B Gabel, N Sidhu, TK Rzesiewicz, R Mandeville, ... Cell stem cell 22 (6), 941-950. e6, 2018 | 356 | 2018 |
The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation CHM Jamieson, J Gotlib, JA Durocher, MP Chao, MR Mariappan, M Lay, ... Proceedings of the National Academy of Sciences 103 (16), 6224-6229, 2006 | 349 | 2006 |
Glycogen synthase kinase 3β missplicing contributes to leukemia stem cell generation AE Abrahamsson, I Geron, J Gotlib, KHT Dao, CF Barroga, IG Newton, ... Proceedings of the National Academy of Sciences 106 (10), 3925-3929, 2009 | 289 | 2009 |
Transcriptome Sequencing Reveals Potential Mechanism of Cryptic 3’ Splice Site Selection in SF3B1-mutated Cancers C DeBoever, EM Ghia, PJ Shepard, L Rassenti, CL Barrett, K Jepsen, ... PLoS computational biology 11 (3), e1004105, 2015 | 241 | 2015 |
ADAR1 activation drives leukemia stem cell self-renewal by impairing Let-7 biogenesis MA Zipeto, A Sadarangani, NPD Santos, L Balaian, HJ Chun, G Pineda, ... Cell stem cell 19 (2), 177-191, 2016 | 220 | 2016 |
A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition DJ Goff, A Sadarangani, HJ Chun, CL Barrett, M Krajewska, H Leu, ... Cell stem cell 12 (3), 316-328, 2013 | 199 | 2013 |
ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia Q Jiang, LA Crews, CL Barrett, HJ Chun, AC Court, JM Isquith, MA Zipeto, ... Proceedings of the National Academy of Sciences 110 (3), 1041-1046, 2013 | 182 | 2013 |
Selective inhibition of JAK2-driven erythroid differentiation of polycythemia vera progenitors I Geron, AE Abrahamsson, CF Barroga, E Kavalerchik, J Gotlib, JD Hood, ... Cancer cell 13 (4), 321-330, 2008 | 180 | 2008 |
Phase I trial: cirmtuzumab inhibits ROR1 signaling and stemness signatures in patients with chronic lymphocytic leukemia MY Choi, GF Widhopf, EM Ghia, RL Kidwell, MK Hasan, J Yu, LZ Rassenti, ... Cell Stem Cell 22 (6), 951-959. e3, 2018 | 172 | 2018 |